National HealthCare Corporation (NHC) — Fair Value Analysis
Base-case fair value (P50): $265.36 · Current price: $223.59 · Verdict: Undervalued
The Verdict on NHC
NATIONAL HEALTHCARE CORP (NHC) is currently Fairly Valued according to our Monte Carlo simulations, which project its median fair value (P50) at $265.36. With the stock trading at $223.59, this implies a potential upside of +18.7% to reach its probabilistic fair value. While modest, this upside aligns with a "Fairly Valued" assessment, indicating that the market price broadly reflects the company's intrinsic value based on thousands of forward-looking scenarios. Our models suggest NHC is not significantly overvalued at its current trading level relative to its calculated P50 fair value.
How NHC stacks up against peers
NHC's quality tier is rated as "average" regarding its operational and financial health compared to sector peers. This average standing suggests a balanced risk-reward profile, where the company's financial stability and operational efficiency are neither outstanding nor a significant concern. While the current price of $223.59 is below the median fair value of $265.36, the average quality tier means investors should weigh this +18.7% against the company's competitive positioning and execution. The simulations account for these underlying fundamentals, confirming the "Fairly Valued" verdict despite the indicated upside.
What this means for investors
For investors, the "Fairly Valued" verdict on NHC suggests that its current trading price of $223.59 offers a reasonable entry point, with the Monte Carlo median fair value target of $265.36 indicating a potential +18.7%. While not presenting a deep value opportunity, the average quality tier signals a steady operator. This scenario implies that future returns are likely to be driven by sustained operational performance rather than a significant re-rating from a heavily undervalued state. Leverage FairCurve to see the full bear and bull distribution and track NHC’s fair value as new fundamentals are released.
Frequently Asked Questions
Is NHC overvalued or undervalued right now?
Based on our Monte Carlo simulations, NATIONAL HEALTHCARE CORP (NHC) is currently considered Fairly Valued. Its current price of $223.59 is below the median fair value (P50) of $265.36.
What is the bear case and bull case for NHC?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate NHC's fair value?
FairCurve employs Monte Carlo simulations to calculate NHC's fair value by analyzing thousands of forward-looking scenarios based on its financial fundamentals and market conditions.
How can I track NHC's fair value as it changes?
You can add NHC to a free FairCurve watchlist for daily fair-value updates and instant re-valuation every time new earnings or significant news are released.